National Beverage earnings in focus as LaCroix battles headwinds

National Beverage (LaCroix) is set to report Q4 earnings of 48 cents/share on $301.08M revenue, with EPS expected to improve 9.5% sequentially but revenue projected to fall 4.1% YoY. UBS’s lone sell rating and $33 target (about 4% upside) reflect doubts on sales momentum, margin risk from higher input costs into FY27, and “consistent top line growth” still being elusive. With the stock near its 52-week low (down sharply from the high) and analysts trimming EPS (-0.5%) and revenue (-0.53%) expectations, the results are likely to move sentiment and potentially the stock 1-3% around the print.

Analysis

The key market mechanism is not “slow growth,” it is the fragility of FIZZ’s margin story if volumes fail to re-accelerate. In a category where shelf-space economics are winner-take-most, a smaller branded player can lose pricing power faster than its gross margin percentage suggests, because fixed overhead deleverage tends to show up one quarter after the sales miss, not on the same print.

The second-order winner is not just the large beverage peers, but any company with distribution reach plus innovation budgets: KO, PEP, and to a lesser extent NSRGY/DANOY are better positioned to absorb functional-line trend shifts and defend end-cap placement. If consumer demand is migrating toward prebiotic/caffeinated variants, the competitive advantage compounds through retailer negotiating leverage and faster product refresh, which can pressure FIZZ for multiple quarters even if the stock already looks cheap on headline P/E.

The contrarian view is that the market may already be discounting a deteriorating category story: near lows, low analyst coverage, and an undemanding multiple mean a merely “not-as-bad” quarter can trigger a reflexive squeeze. The thesis is falsified if management can show sequential volume stabilization, gross margin holding above the mid-37% range despite input inflation, and no need to re-trade growth expectations for FY27. Absent that, the next 1-3 months remain a de-rating window, with the longer risk being structural share loss to scaled incumbents and private label.

Key Decisions for Investors

• Short FIZZ into the print or via near-dated put spreads if implied move is not already pricing a downside miss; initial downside target is a re-test of the low-20s if revenue and margin trends disappoint, with a tight stop if management frames a credible volume inflection.
• Pair trade: long KO or PEP vs short FIZZ for 1-3 months. Rationale: scaled peers can outspend on functional innovation and defend shelf space while FIZZ bears the burden of fixed-cost deleverage; this is the cleaner expression than a naked beverage short.
• If you want event convexity, use a bearish options structure on FIZZ rather than stock, because the stock is already near its 52-week low and a small positive surprise could force a squeeze; keep risk limited to premium paid.
• Set a watch item on gross margin and sequential revenue cadence post-earnings. If either stabilizes, cover shorts quickly; if management guides to softer FY27 margin trajectory, expect further multiple compression over the next 1-3 quarters.